Becton Dickinson Shares Outstanding 2012-2026 | BDX

Becton Dickinson shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Becton Dickinson shares outstanding for the quarter ending March 31, 2026 were 0.281B, a 2.47% decline year-over-year.
  • Becton Dickinson 2025 shares outstanding were 0.289B, a 0.86% decline from 2024.
  • Becton Dickinson 2024 shares outstanding were 0.291B, a 0.91% increase from 2023.
  • Becton Dickinson 2023 shares outstanding were 0.288B, a 0.36% increase from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Becton Dickinson Annual Shares Outstanding
(Millions of Shares)
2025 289
2024 291
2023 288
2022 287
2021 292
2020 282
2019 275
2018 265
2017 224
2016 218
2015 208
2014 198
2013 199
2012 209
2011 226
Becton Dickinson Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 281
2025-12-31 286
2025-09-30 289
2025-06-30 287
2025-03-31 288
2024-12-31 290
2024-09-30 291
2024-06-30 290
2024-03-31 290
2023-12-31 291
2023-09-30 288
2023-06-30 288
2023-03-31 286
2022-12-31 285
2022-09-30 287
2022-06-30 287
2022-03-31 287
2021-12-31 287
2021-09-30 292
2021-06-30 292
2021-03-31 294
2020-12-31 293
2020-09-30 282
2020-06-30 285
2020-03-31 275
2019-12-31 275
2019-09-30 275
2019-06-30 274
2019-03-31 270
2018-12-31 274
2018-09-30 265
2018-06-30 274
2018-03-31 267
2017-12-31 230
2017-09-30 224
2017-06-30 221
2017-03-31 218
2016-12-31 218
2016-09-30 218
2016-06-30 217
2016-03-31 217
2015-12-31 216
2015-09-30 208
2015-06-30 215
2015-03-31 200
2014-12-31 197
2014-09-30 198
2014-06-30 197
2014-03-31 197
2013-12-31 198
2013-09-30 199
2013-06-30 199
2013-03-31 198
2012-12-31 200
2012-09-30 209
2012-06-30 205
2012-03-31 210
2011-12-31 218
2011-09-30 226
2011-06-30 224
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $43.913B $21.840B
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
STAAR Surgical (STAA) United States $1.309B 0.00
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00